INCY
Incyte Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.
Market Cap: 13.3 Billion
Primary Exchange: NASDAQ
Website: https://www.incyte.com/
Shares Outstanding: 225 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.4960416466638585
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Ethical Flags
Longest drawdown: 2111 trading days
From: 2017-03-15 To: 2024-03-07
Lowest Point:
Concert Pharmaceuticals: Cheap Valuation With Multiple Programs Moving Forward
via: SeekingAlpha at 2019-06-13 09:46:22:000
Shares of Concert Pharmaceuticals ( CNCE ) have provided quite the roller coaster ride for investors. The stock was a winner for us the first time around , as it tripled after my original recommendation (due to a lucrative deal inked with Vertex Pharmaceuticals (VRTX)). Subsequent recommendat… read more...
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|